Provided by Tiger Fintech (Singapore) Pte. Ltd.

Celestica

85.30
+4.715.84%
Volume:1.49M
Turnover:124.52M
Market Cap:9.89B
PE:23.63
High:85.68
Open:81.93
Low:80.99
Close:80.59
Loading ...

QCOM Unveils Advanced Chipsets for Immersive Gaming: Stock to Gain?

Zacks
·
18 Mar

HLIT Enhances Video Streaming Technology With New Origin Capabilities

Zacks
·
18 Mar

ADTN Solutions to Boost Italy's Digital Infrastructure: Stock to Gain?

Zacks
·
18 Mar

Will CommScope Stock Gain From the Expansion of Propel Portfolio?

Zacks
·
14 Mar

Viavi Simplifies Testing of Mission Critical Radio: Stock to Gain?

Zacks
·
14 Mar

High Growth Tech Stocks to Watch in March 2025

Simply Wall St.
·
14 Mar

Celestica Inc. (CLS): A Bull Case Theory

Insider Monkey
·
14 Mar

CLS Holdings Executives Acquire Shares Under Incentive Plan

TIPRANKS
·
14 Mar

Motorola Solution Boosts Safety of San Luis Police: Stock to Gain?

Zacks
·
13 Mar

Will the Launch of Isolated Probing Technology Aid Keysight?

Zacks
·
12 Mar

Nokia Boosts Outer Reach Broadband Network With Advanced Solutions

Zacks
·
12 Mar

IBM watsonx Powers Mitsubishi Motors' AI Initiative: Stock to Gain?

Zacks
·
11 Mar

Is CLS Stock a Solid Buy Option Despite the Recent Slump?

Zacks
·
11 Mar

Ericsson Boosts Digital Infrastructure in Africa: Stock to Gain?

Zacks
·
10 Mar

VSAT Showcases SATCOM Innovation for Automotive Sector: Stock to Gain?

Zacks
·
10 Mar

MSI Boosts Situational Awareness of Australian Police: Stock to Gain?

Zacks
·
08 Mar

Promising Potential of Clearside Biomedical’s CLS-AX Treatment Justifies Buy Rating

TIPRANKS
·
07 Mar

TMUS Expands Market Opportunity With Strategic Buyouts: Stock to Gain?

Zacks
·
06 Mar

Clearside Biomedical announces successful End-of-Phase 2 meeting for CLS-AX

TIPRANKS
·
06 Mar

Clearside Biomedical Announces Successful End-of-Phase 2 Meeting with the FDA and Alignment on Phase 3 Plans for Suprachoroidal CLS-AX in Wet AMD

GlobeNewswire
·
06 Mar